Here begins the search for molecular targets to create new drugs to benefit your business, and medicine in General.
The study of molecular mechanisms of carcinogenesis, genetic and epigenetic changes in the tumor genome that determine the development, prognosis and treatment of malignant tumors.
The study of the genome in hereditary diseases.
We study the role of TRP and ASIC channels in the development of such neurodegenerative diseases as Parkinson's and Alzheimer's diseases. Fundamental mechanisms of pathogenesis of these diseases involving these channels are being investigated. Also, a search for compounds that are able to modulate their work and to influence the rate of progression of neurodegeneration.
One of the promising areas that are already recognized and supported by grants, is to create smart scaffolds – a fundamentally new nanocomposite materials that provide interactive assessment of implants and controlled therapeutic effects in the area of implantation, as well as the scale of the whole organism.
The creation and adaptation of contrasting materials, including photoluminescent nanomaterials, for contrast visualization of scaffolds. Creating imaging systems that can determine the topical position of the implanted scaffold, the morphological and functional condition.
Synthesis of optically contrasting nanomaterials. The creation of a managed container that allows to release the biologically active substances in the field of regenerated tissue in the entire body. The devices are biocompatible scaffold and filling them smart materials for control and visualization.
Sequencing of gene panels associated with various human diseases.
Determination of the nucleotide sequences of plasmids and PCR products.
Study of the activities of compounds relative to the receptor TRPV1, TRPV2, TRPV3, and TRPA1 channels ASIC1, ASIC3
Genotyping STR markers, detection of allele imbalance.
Real-time PCR for determining copy number of a matrix and analysis of gene expression in the framework of the agreement on research work.
Testing conditions the performance of genetic analysis using the polymerase chain reaction (PCR) in various modifications.
At the forefront of molecular medicine
We can truly be proud of staff of Andrei Aleksandrovich. Approximately half of the staff are professors, associate professors and Ph, the other half of the candidates and doctors of sciences
Pay attention of scientific community to your developments and enlist powerful support.
See the benefits of partnership
Use the form below, to discuss the details of an ordered research in the Institute of a molecular medicine.
Your request has been sent. We will contact you shortly
Use the form below to get a free consultation with Andrey Zamyatnin.
Your request has been sent. We will contact you shortly
